News

Business Wire22d
Aviceda Therapeutics Appoints Industry Veteran Dr. Jeffrey Nau as Chief Executive Officer to Lead Next Phase of Growth and Innovation
today announced the appointment of Jeffrey Nau, Ph.D., M.M.S., as Chief Executive Officer (CEO), effective immediately. Dr. Nau will also join the Aviceda Board of Directors. Dr. Nau is an ...
Nasdaq13d
Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors
adds significant depth to our Board at a time of meaningful momentum for Aviceda,” said Jeffrey Nau, Ph.D., M.M.S., President and Chief Executive Officer of Aviceda Therapeutics. “His unique ...
Yahoo Finance22d
Aviceda Therapeutics Appoints Industry Veteran Dr. Jeffrey Nau as Chief Executive Officer to Lead Next Phase of Growth and Innovation
today announced the appointment of Jeffrey Nau, Ph.D., M.M.S., as Chief Executive Officer (CEO), effective immediately. Dr. Nau will also join the Aviceda Board of Directors. Dr. Nau is an ...